-
Lpath, Inc. (NASDAQ: LPTN) shares jumped 58.17
percent to $3.29 as the company reported that it has been awarded a $1.45 million 2-year grant for traumatic brain injury pain
study.
-
Fate Therapeutics Inc (NASDAQ: FATE) gained 19.90
percent to $2.01 as the company reported the FDA Fast Track designation for ProTmune.
-
Neovasc Inc (US) (NASDAQ: NVCN) shares surged
17.66 percent to $0.900 as the company reported that positive results for Reducer system treatment for refractory angina were
published in The Netherlands Heart Journal.
-
Cerus Corporation (NASDAQ: CERS) shares gained
8.77 percent to $6.20 as the company announced an agreement Sunday with the BARDA for potential funding of up to $180 million
to advance INTERCEPT red blood cell program.
-
Yelp Inc (NYSE: YELP) shares rose 7.65 percent to
$28.98. Deutsche Bank upgraded Yelp from Hold to Buy and raised the price target from $26.00 to $33.00.
-
Murphy Oil Corporation (NYSE: MUR) gained 6 percent
to $31.11. Raymond James upgraded Murphy Oil from Underperform to Market Perform.
-
Vale SA (ADR) (NYSE: VALE) shares surged 5.9
percent to $4.72. Mosaic Co (NYSE: MOS) is said to
be in talks to acquire Vale fertilizer unit, according to sources as reported by Reuters on Friday.
-
Chesapeake Energy Corporation (NYSE: CHK) shares
rose 5 percent to $4.74. Crude oil traded gained 2.5 percent to $49.17 a barrel.
-
Spirit Airlines Incorporated (NASDAQ: SAVE)
gained 5 percent to $44.50. Credit Suisse upgraded Spirit Airlines from Neutral to Outperform, while raising the target price
from $44 to $55.
-
Inovio Pharmaceuticals Inc (NYSE: INO) shares rose 3
percent to $10.78 in pre-market trading. Inovio Pharmaceuticals and GeneOne Life Science reported that they have received
approval for first-in-man Zika vaccine clinical trial.
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.